GenMark Q2 Revenues Rise 27 Percent | GenomeWeb

NEW YORK (GenomeWeb) – GenMark Diagnostics reported after the close of the market on Monday that its second quarter revenues increased 27 percent year over year.

For the three months ended June 30, the company posted $6.6 million in revenues, up from $5.2 million in the year-ago quarter, and above the average analyst estimate of $4.8 million. GenMark had preannounced in July its second quarter revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.